surmount-1 tirzepatide non-diabetic weight loss Gastrointestinal tolerability and reduction associated with in adults with obesity or overweight with and without type 2 diabetes in the SURMOUNT‐1 to ‐4 trials - Rubino - 2025 SURMOUNT-1 Trial - Cardionerds Twitter

(2025, June)

Your clinician will recommend the medication that makes the most sense for your health history, insurance, and goals

Tirzepatide injections are available through supervised medical weight loss clinics

Discontinue MOUNJARO if suspected and promptly seek medical advice

(PMC) What the research shows Extensive clinical trials like SURMOUNT-1 have shown that tirzepatide can help people lose up to 20% or more of their body weight , which is far more than most older weight-loss medications

Monitoring Response Weight trends, appetite changes, and side effects are often monitored closely during the first several weeks to guide adjustments